Search

Author/Creator Geusens, P P

2. Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study. Issue 7 (15th September 2008)

Authors:
Combe, B; Codreanu, C; Fiocco, U; Gaubitz, M; Geusens, P P; Kvien, T K; Pavelka, K; Sambrook, P N; Smolen, J S; Khandker, R; Singh, A; Wajdula, J; Fatenejad, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 7(2009)
Page Start:
1146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Issue 10 (10th April 2006)

Authors:
Combe, B; Codreanu, C; Fiocco, U; Gaubitz, M; Geusens, P P; Kvien, T K; Pavelka, K; Sambrook, P N; Smolen, J S; Wajdula, J; Fatenejad, S
Other Names:
group-author.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 65:Issue 10(2006)
Page Start:
1357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial. Issue 4 (17th November 2006)

Authors:
Kavanaugh, A; Krueger, G G; Beutler, A; Guzzo, C; Zhou, B; Dooley, L T; Mease, P J; Gladman, D D; de Vlam, K; Geusens, P P; Birbara, C; Halter, D G; Antoni, C
Other Names:
group-author.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 66:Issue 4(2007)
Page Start:
498
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗